Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Wellcome Open Research|December 7, 2020
Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South AfricaLouise O Downs, Sabeehah Vawda, Phillip Armand Bester, et al.
European Journal of Immunology|December 27, 2021
Adenovirus vectors activate Vδ2<sup>+</sup> γδT cells in a type I interferon-, TNF-, and IL-18-dependent mannerNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Journal of Hepatology|September 17, 2013
Multiparametric magnetic resonance for the non-invasive diagnosis of liver diseaseRajarshi Banerjee, Michael Pavlides, Elizabeth M Tunnicliffe, et al.
Clinical and Experimental Immunology|May 6, 2022
Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workersEloise Phillips, Sandra Adele, Tom Malone, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101Femke Stelma, Meike H van der Ree, Marjan J Sinnige, et al.
Wellcome Open Research|December 16, 2016
Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virusSheila Lumley, Howard Noble, Martin J Hadley, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 15, 2020
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adultsJolynne Mokaya, Tongai G Maponga, Anna L McNaughton, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
Antiviral Research|August 29, 2017
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosingMeike H van der Ree, Femke Stelma, Sophie B Willemse, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 29, 2025
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studiesMaria Danysz, Rute Cardoso De Aguiar, Hema Pindolia, et al.
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Wellcome Open Research|December 7, 2020
Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South AfricaLouise O Downs, Sabeehah Vawda, Phillip Armand Bester, et al.
European Journal of Immunology|December 27, 2021
Adenovirus vectors activate Vδ2<sup>+</sup> γδT cells in a type I interferon-, TNF-, and IL-18-dependent mannerNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Journal of Hepatology|September 17, 2013
Multiparametric magnetic resonance for the non-invasive diagnosis of liver diseaseRajarshi Banerjee, Michael Pavlides, Elizabeth M Tunnicliffe, et al.
Clinical and Experimental Immunology|May 6, 2022
Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workersEloise Phillips, Sandra Adele, Tom Malone, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101Femke Stelma, Meike H van der Ree, Marjan J Sinnige, et al.
Wellcome Open Research|December 16, 2016
Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virusSheila Lumley, Howard Noble, Martin J Hadley, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 15, 2020
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adultsJolynne Mokaya, Tongai G Maponga, Anna L McNaughton, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
Antiviral Research|August 29, 2017
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosingMeike H van der Ree, Femke Stelma, Sophie B Willemse, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 29, 2025
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studiesMaria Danysz, Rute Cardoso De Aguiar, Hema Pindolia, et al.
Pageof 23